Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

M-020

Supelco

S(+)-Methamphetamin -Lösung

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Synonym(e):

Dextro-Methamphetamin

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C10H15N
CAS-Nummer:
537-46-2
Molekulargewicht:
149.23
MDL-Nummer:
MFCD00079140
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329817739
NACRES:
NA.24

Qualität

certified reference material

Qualitätsniveau

300

Form

liquid

Leistungsmerkmale

Snap-N-Spike®/Snap-N-Shoot®

Verpackung

ampule of 1 mL

Hersteller/Markenname

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)

Konzentration

1.0 mg/mL in methanol

Methode(n)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Anwendung(en)

forensics and toxicology

Format

single component solution

Lagertemp.

2-8°C

SMILES String

CN[C@@H](C)Cc1ccccc1

InChI

1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1

InChIKey

MYWUZJCMWCOHBA-VIFPVBQESA-N

Angaben zum Gen

human ... SLC6A2(6530) , SLC6A3(6531) , SLC6A4(6532)

Verwandte Kategorien

Allgemeine Beschreibung

Methamphetamin ist eine psychostimulierende Droge aus der Stoffgruppe der Phenethylamine und Amphetamine. Diese umgangssprachlich auch als „Meth“, „Ice“ und „Crystal“ bekannte Snap-N-Spike®-Referenzlösung eignet sich für den Einsatz in LC-MS- oder GC-MS-Anwendungen zum Beispiel in der klinischen Toxikologie, bei Tests im Sport und in der forensischen Analytik oder der Urin-Drogenkontrolle. Das rechtsdrehende Isomer von Methamphetamin wird unter dem Handelsnamen Desoxyn® zur Behandlung von ADHS und Adipositas verkauft.

Anwendung


  • Pharmacokinetic Studies of S(+)-Methamphetamine: A comprehensive study assessing the pharmacokinetic profile of S(+)-Methamphetamine highlighted its rapid absorption and metabolism, offering critical insights into its therapeutic potential and challenges in drug abuse scenarios. This research aids in optimizing dosing regimens and understanding the drug′s behavior in biological systems, essential for both clinical applications and forensic investigations (Rushton et al., 2024).

  • Pharmaceutical Applications of S(+)-Methamphetamine: Research on S(+)-Methamphetamine′s role in neurochemical processes explored its effects on neurotransmitter systems, particularly focusing on its potential therapeutic applications for attention deficit hyperactivity disorder (ADHD) and weight loss. Studies like these inform drug design and repurposing strategies, helping to mitigate abuse risks while harnessing pharmacological benefits (Pardo et al., 2024).

  • Drug Metabolism and Enantiomeric Analysis: Investigations into the metabolism of S(+)-Methamphetamine have provided detailed insights into its biotransformation pathways, crucial for developing antidotes and treatment strategies for overdose cases. This research also enhances the understanding of enantiomeric differences in drug activity, supporting the development of more targeted and effective therapeutic agents (Liut et al., 2024).

  • Clinical Trials and Neurological Research: Systematic reviews of clinical trials involving S(+)-Methamphetamine have elucidated its complex pharmacodynamics and associated behavioral effects. This information is vital for neuroscientists and pharmacologists working to develop safer and more effective CNS stimulants with fewer side effects and lower abuse potential (Barkholtz et al., 2023).

Rechtliche Hinweise

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Desoxyn is a registered trademark of Abbott Laboratories Corp.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

M-023

(±)-Methamphetamin-D5 -Lösung, 1 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-090

(±)-Methamphetamin-D9 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-091

(±)-Methamphetamin-D9 -Lösung, 1 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

A-050

Amin-Mischung 6 -Lösung, 250 μg/mL each component in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-025

Methamphetamin/Cocain/Heroin -Lösung, 250 μg/mL each component in acetonitrile, ampule of 1.0 mL, certified reference material, Cerilliant®

M-004

(±)-Methamphetamin-D5 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-009

(±)-Methamphetamin -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-016

(±)-Methamphetamin-D8 -hydrochlorid -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-022

(±)-Methamphetamin -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-024

R(-)-Methamphetamin -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-034

(±)-Methamphetamin-D8 -hydrochlorid -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-059

(±)-Methamphetamin-D11 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-060

(±)-Methamphetamin-D11 -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-092

(±)-Methamphetamine-D14 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-093

(±)-Methamphetamine-D14 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Signalwort

Danger

Gefahreneinstufungen

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Zielorgane

Eyes

Lagerklassenschlüssel

3 - Flammable liquids

WGK

WGK 1

Flammpunkt (°F)

49.5 °F - closed cup

Flammpunkt (°C)

9.7 °C - closed cup

Zulassungslistungen

Zulassungslistungen werden hauptsächlich für chemische Produkte erstellt. Für nicht-chemische Produkte können hier nur begrenzte Angaben gemacht werden. Kein Eintrag bedeutet, dass keine der Komponenten gelistet ist. Es liegt in der Verantwortung des Benutzers, die sichere und legale Verwendung des Produkts zu gewährleisten.

EU REACH Annex XVII (Restriction List)

CAS No.

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 6

1 of 6

Morphin -Lösung 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

M-030

Morphin -Lösung

Kokain -Lösung 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

C-008

Kokain -Lösung

Benzoylecgonin -Lösung 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

B-004

Benzoylecgonin -Lösung

(±)-MDMA -Lösung 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

M-013

(±)-MDMA -Lösung

(±)-Amphetamin -Lösung 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

A-007

(±)-Amphetamin -Lösung

(±)-Methamphetamin-D5 -Lösung 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

M-004

(±)-Methamphetamin-D5 -Lösung

Amy J Eshleman et al.
Biochemical pharmacology, 85(12), 1803-1815 (2013-04-16)
The use of synthetic methcathinones, components of "bath salts," is a world-wide health concern. These compounds, structurally similar to methamphetamine (METH) and 3,4-methylendioxymethamphetamine (MDMA), cause tachycardia, hallucinations and psychosis. We hypothesized that these potentially neurotoxic and abused compounds display differences
Ronni E Brown et al.
Journal of the California Dental Association, 41(6), 421-428 (2013-07-24)
Meth mouth is the rapid development of tooth decay in methamphetamine users. Our study questioned whether drug-use patterns and dental care access are risk factors affecting the severity of meth mouth. Participants received dental examinations, and the number of decayed
Brett A Dolezal et al.
Journal of addiction medicine, 7(2), 122-128 (2013-04-05)
Physical exercise has been shown to benefit diverse medical and behavioral conditions. This study assesses the feasibility and efficacy of an 8-week endurance and resistance training program on fitness measures in individuals undergoing residential treatment for methamphetamine (MA) dependence. A
Jeffrey T Parsons et al.
AIDS and behavior, 17(4), 1478-1487 (2013-04-05)
Methamphetamine use is associated with HIV infection, especially among gay and bisexual men. Methamphetamine use contributes to disease progression both directly, by increasing viral load and damaging the immune system, and indirectly, by decreasing medication adherence. Research examining the association
Glen R Hanson et al.
The Journal of pharmacology and experimental therapeutics, 346(2), 173-181 (2013-05-21)
Because of persistent social problems caused by methamphetamine (METH), new therapeutic strategies need to be developed. Thus, we investigated the response of central nervous system neurotensin (NT) systems to METH self-administration (SA) and their interaction with basal ganglia dopamine (DA)
Alle zugehörigen Dokumente anzeigen

Protokolle

Accurate Biological Testing for Amphetamine and Methamphetamine Abuse Using Chiral HPLC and MS Detection

Optimized sample prep and chiral chromatography methods for the LC/MS analysis of these drug enantiomers in urine

Biological Testing for Amphetamine and Methamphetamine Abuse

In this study, optimized methods are presented for sample preparation and chiral chromatography for the LC/MS analysis of amphetamine and methamphetamine enantiomers in urine.

LC/MS Analysis of Methamphetamine Enantiomers on Astec® CHIROBIOTIC® V2 in Urine after SPE using Supel™-Select SCX

LC/MS Analysis of Methamphetamine Enantiomers on Astec® CHIROBIOTIC® V2 in Urine after SPE using Supel™-Select SCX

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.